Filariasis test strips (FTS) | P | |||
---|---|---|---|---|
Negative | Positive | Total | ||
Mass drug administration for LF*, n (%) | < 0.001** | |||
No | 1155 (97.9) | 25 (2.1) | 1180 | |
Yes | 170 (83.7) | 33 (16.3) | 203 | |
Unknown | 8 (100.0) | 0 (0.0) | 8 | |
ITN availability*, n (%) | 0.354* | |||
No | 505 (95.1) | 26 (4.9) | 531 | |
Yes | 828 (96.3) | 32 (3.7) | 860 | |
ITN use* during the night before the survey, n (%) | 0.657** | |||
No | 667 (95.6) | 31 (4.4) | 698 | |
Yes | 651 (96.0) | 27 (4.0) | 678 | |
Unknown | 15 (100.0) | 0 (0.0) | 15 | |
History of LF complications, n (%) | < 0.001* | |||
No | 1297 (96.3) | 50 (3.7) | 1347 | |
Yes | 36 (81.8) | 8 (18.2) | 44 | |
Type of LF complication (n = 44), n (%) | 0.006** | |||
Elephantiasis/ lymphedema | 11 (100.0) | 0 (0.0) | 11 | |
Hydrocele/ elephantiasis/ lymphedema | 2 (66.7) | 1 (33.3) | 3 | |
Hydrocele | 19 (90.5) | 2 (9.5) | 21 | |
Unknown | 4 (44.4) | 5 (55.6) | 9 | |
Ever ivermectin (for onchocerciasis) and/or albendazole (for STH) distribution, n (%) | < 0.001** | |||
No | 1322 (100.0) | 0 (0.0) | 1322 | |
Yes | 11 (15.9) | 58 (84.1) | 69 | |
Type of migrant, n (%) | < 0.001* | |||
Economic migrant | 432 (98.9) | 5 (1.1) | 437 | |
Nomad Peuhl | 325 (88.1) | 44 (11.9) | 369 | |
Refugee | 576 (98.5) | 9 (1.5) | 585 |